Pain Management in Intensive Care Unit Patients: the Role of Ultra-short Acting Opioid: Remifentanil
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Luo J, Lu S, Fu X, Shen J, He H, Pan C Pain Ther. 2024; 13(6):1695-1704.
PMID: 39424775 PMC: 11543959. DOI: 10.1007/s40122-024-00669-4.
Nasiri M, Fayazi S, Ghaderi M, Naseri M, Adarvishi S Anesth Pain Med. 2015; 4(5):e23149.
PMID: 25729678 PMC: 4333306. DOI: 10.5812/aapm.23149.
Volatile anesthetics in ischemic liver injury: enemy or friend?.
Mohseni M, Safari S, Alavian S Hepat Mon. 2014; 14(6):e19880.
PMID: 24976844 PMC: 4071358. DOI: 10.5812/hepatmon.19880.
References
1.
Chalumeau-Lemoine L, Stoclin A, Billard V, Laplanche A, Raynard B, Blot F
. Flexible fiberoptic bronchoscopy and remifentanil target-controlled infusion in ICU: a preliminary study. Intensive Care Med. 2012; 39(1):53-8.
DOI: 10.1007/s00134-012-2697-7.
View
2.
Egan T, Lemmens H, Fiset P, Hermann D, Muir K, Stanski D
. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology. 1993; 79(5):881-92.
DOI: 10.1097/00000542-199311000-00004.
View
3.
Westmoreland C, Hoke J, Sebel P, HUG Jr C, Muir K
. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology. 1993; 79(5):893-903.
DOI: 10.1097/00000542-199311000-00005.
View
4.
Karabinis A, Mandragos K, Stergiopoulos S, Komnos A, Soukup J, Speelberg B
. Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]. Crit Care. 2004; 8(4):R268-80.
PMC: 522854.
DOI: 10.1186/cc2896.
View
5.
Soliman H, Melot C, Vincent J
. Sedative and analgesic practice in the intensive care unit: the results of a European survey. Br J Anaesth. 2001; 87(2):186-92.
DOI: 10.1093/bja/87.2.186.
View